Legal and Business Risks in Health-Care Transactions

Document Type

Practice Advisory

Publication Date

9-2020

Publisher

Bloomberg Industry Group, Inc

Language

en-US

Abstract

The Covid-19 pandemic has triggered immediate and lasting changes to the health-care industry. As the U.S. economy reopens and health-care transactions rekindle, parties to mergers, acquisitions, joint ventures, and affiliations will need to evaluate new legal and business risks related to the pandemic. This article discusses five key topics that organizations should consider when evaluating health-care transactions during and after the Covid-19 crisis.

This document is currently not available here.

Publisher Link

Share

COinS